Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 3/2016

01-03-2016 | Erratum

Erratum to: Cariprazine: First Global Approval

Author: Paul L. McCormack

Published in: Drugs | Issue 3/2016

Login to get access

Excerpt

Page 2038, Sect. 2.3.1 Schizophrenia, second paragraph, third sentence, which previously read: …
Metadata
Title
Erratum to: Cariprazine: First Global Approval
Author
Paul L. McCormack
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Drugs / Issue 3/2016
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-016-0547-6

Other articles of this Issue 3/2016

Drugs 3/2016 Go to the issue

Leading Article

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Adis Drug Evaluation

Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus

AdisInsight Report

Selexipag: First Global Approval

Review Article

Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis

AdisInsight Report

Ixazomib: First Global Approval

Review Article

Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy